HITS Inc. - FuturePlay Portfolio Company Details

HITS is a faculty-founded startup established by Professor Wooyeon Kim of KAIST, specializing in a generative AI-driven drug discovery platform that integrates physical chemistry and deep learning. The platform incorporates K-Fold, a Korean-developed AI model for biotechnology. K-Fold predicts not only the three-dimensional structures of proteins but also their interactions with drug candidates, supporting binding prediction, a critical process in the early stages of drug discovery. In various benchmarks, K-Fold has outperformed leading global models, including AlphaFold 3 and Boltz-2. Building on this technology, HITS operates HyperLab, an AI-powered drug discovery platform that supports the entire early-stage drug discovery process, including target analysis, virtual screening, molecular design, and ADME/T prediction, within a single integrated platform. HyperLab is currently being utilized by various pharmaceutical companies and research institutions in Korea and internationally.